USP18 and hepatocellular carcinoma: To elucidate the principal downstream mediator responsible for USP18-mediated sorafenib resistance in HCC, we conducted cluster analysis on the differential protein expression based on the whole-proteome analysis of HepG2 cells with or without overexpression of USP18 (HepG2-USP18-OE vs. HepG2-Ctrl).